Salivary Disease and Cancer
The Division of Head and Neck Cancer and Reconstructive Surgery has a significant interest in advancing the understanding of and driving the science behind the management of salivary disease by studying tumor markers, imaging findings and patient outcomes.
Mayo Clinic's high surgical volumes allow the division to meaningfully investigate and learn from patients receiving treatment — even those with rare diseases. The division has active investigations in areas including but not limited to:
- Carcinoma ex pleomorphic adenoma
- Mucoepidermoid carcinoma
- Parapharyngeal space tumors
- Primary and recurrent salivary gland tumors (pleomorphic adenoma)
Collaboration with other teams, such as the Department of Laboratory Medicine and Pathology and the Department of Radiology, has allowed the Division of Head and Neck Cancer and Reconstructive Surgery to delve into the molecular makeup of these tumors and learn more about their imaging presentation.
- Chintakuntlawar AV, Shon W, Erickson-Johnson M, Bilodeau E, Jenkins SM, Davidson JA, Keeney MG, Rivera M, Price DL, Moore EJ, Olsen KD, Kasperbauer JL, Foote RL, Price KA, García JJ. High-grade transformation of acinic cell carcinoma: an inadequately treated entity? Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2016; doi:10.1016/j.oooo.2016.01.011.
- Cockerill CC, Gross BC, Contag S, Rein S, Moore EJ, Olsen KD, Orvidas LJ. Pediatric malignant salivary gland tumors: 60 year follow up. International Journal of Pediatric Otorhinolaryngology. 2016; doi:10.1016/j.ijporl.2016.05.021.
- Thom JJ, Moore EJ, Price DL, Kasperbauer JL, Starkman SJ, Olsen KD. The role of total parotidectomy for metastatic cutaneous squamous cell carcinoma and malignant melanoma. JAMA Otolaryngology — Head & Neck Surgery. 2014; doi:10.1001/jamaoto.2014.352.